The L76V mutation in HIV-1 protease is potentially associated with hypersusceptibility to protease inhibitors Atazanavir and Saquinavir: is there a clinical advantage?
about
Potent Antiviral HIV-1 Protease Inhibitor GRL-02031 Adapts to the Structures of Drug Resistant Mutants with Its P1′-Pyrrolidinone RingDrug Resistance Conferred by Mutations Outside the Active Site through Alterations in the Dynamic and Structural Ensemble of HIV-1 ProteaseDescription of the L76V resistance protease mutation in HIV-1 B and "non-B" subtypesPrototypical Recombinant Multi-Protease-Inhibitor-Resistant Infectious Molecular Clones of Human Immunodeficiency Virus Type 1Collinearity of protease mutations in HIV-1 samples with high-level protease inhibitor class resistanceHIV-GRADE: a publicly available, rules-based drug resistance interpretation algorithm integrating bioinformatic knowledge.Drug Resistance Mutation L76V Alters Nonpolar Interactions at the Flap-Core Interface of HIV-1 Protease
P2860
Q27677939-DDA86509-DD39-4945-BD1B-13D195A50448Q27684933-330FD3E2-38CE-4111-BD74-591B873D7359Q34563005-E1F82B55-4A0C-4522-A484-4CC6E816EED4Q37124113-86B8D67F-1E8D-43B1-8A1E-4C0A757EFD5FQ42704311-CE506C8D-2C95-4165-A59E-DFEEC8C3A42DQ50145794-76887328-9F2A-4CD7-8200-A935BC265FF3Q57063482-BFB09C25-963F-49BA-826D-D86AE1459C94
P2860
The L76V mutation in HIV-1 protease is potentially associated with hypersusceptibility to protease inhibitors Atazanavir and Saquinavir: is there a clinical advantage?
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The L76V mutation in HIV-1 pro ...... is there a clinical advantage?
@ast
The L76V mutation in HIV-1 pro ...... is there a clinical advantage?
@en
The L76V mutation in HIV-1 pro ...... is there a clinical advantage?
@nl
type
label
The L76V mutation in HIV-1 pro ...... is there a clinical advantage?
@ast
The L76V mutation in HIV-1 pro ...... is there a clinical advantage?
@en
The L76V mutation in HIV-1 pro ...... is there a clinical advantage?
@nl
prefLabel
The L76V mutation in HIV-1 pro ...... is there a clinical advantage?
@ast
The L76V mutation in HIV-1 pro ...... is there a clinical advantage?
@en
The L76V mutation in HIV-1 pro ...... is there a clinical advantage?
@nl
P2093
P2860
P50
P356
P1476
The L76V mutation in HIV-1 pro ...... is there a clinical advantage?
@en
P2093
André Tappe
Frank Wiesmann
Gudrun Naeth
Hauke Walter
Heribert Knechten
Jan Vachta
Martin Däumer
Patrick Braun
Robert Ehret
Rolf Kaiser
P2860
P2888
P356
10.1186/1742-6405-8-7
P577
2011-02-13T00:00:00Z
P5875
P6179
1030515323